Enovis Corp. (ENOV)
26.47
-1.35
(-4.85%)
USD |
NYSE |
Dec 12, 16:00
26.46
-0.01
(-0.04%)
After-Hours: 20:00
Enovis Research and Development Expense (Quarterly): 29.74M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Baxter International, Inc. | 115.00M |
| Integra LifeSciences Holdings Corp. | 20.42M |
| Merit Medical Systems, Inc. | 23.97M |
| Repligen Corp. | 14.18M |
| Perspective Therapeutics, Inc. | 19.56M |